BREATHOX® is a safe and effective expectorant indicated in enhancement of mucociliary clearance, and in the alleviation of nasal and bronchial congestion.

The treatment is non-medical and based on salt particle inhalation.

BREATHOX® improves quality of life for consumers by improving and maintaining their ability to breathe more comfortably.


Breathox® is the worlds first salt particle inhaler*.

The patented breath-actuated device allows the consumer to use the product comfortably at home or on-the-go.

The Sodium Chloride ingredient is based on salt directly extracted from a 280 million year old salt tectonic in Northern Denmark.  Subsequently, this raw material is processed into pharmaceutical grade NaCl complying with the monographs of all int. pharmacopoeia; Ph. Eur., USP, JP, KP, Ph. Rus. This unique technology makes the Breathox an unprecedented, drug-free offer to consumers with respiratory challenges.

Breathox® is developed by a team of leading Scandinavian scientist, designers and engineers.


*) The dispensed NaCl micro particle size range from 1-10µm allowing respiratory application.


Breathox® is an OTC product targeted at the following consumer segments:


  • chronic or temporary respiratory patients
  • allergy sufferers
  • smokers and ex-smokers


Together these segments consist of more than 25% of the international OTC market.